Pay in 4 interest-free payments of $5.56 Learn more
Ships within 48 hours · Estimated delivery Sep 27 - Oct 2
In rare cases, GLP-1 receptor agonists can lead to more serious side effects, such as pancreatitis (inflammation of the pancreas), thyroid tumours, or kidney problems
Contrastingly, GLP1 antagonist sales in 2023 showcase a more diversified landscape, with therapeutics such as Ozempic, Trulicity, and Mounjaro driving 71 per cent of the sales. Looking ahead, the GLP1 agonist market is poised for robust growth, anticipating a 19.2 per cent compound annual growth rate (CAGR) from 2023 to 2029, reaching a substantial market size of $105 billion in 2029
Uncover the role of homocysteine-lowering B vitamins, particularly B12, in promoting cardiovascular health and delve into the potential benefits within the spectrum of supplementation options
It is also leveraging connected devices and mobile apps to support adherence and remote monitoring
